SCHEMBL5865513

SCHEMBL5865513

Nc1cc(/C=C/c2ccccc2)ccn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.53
MAOA P21397 2/20 0.53
MAOB P27338 2/20 0.53
GRM4 Q14833 6/20 0.53
HDAC6 Q9UBN7 1/20 0.53
KDM4E B2RXH2 3/20 0.52
ALDH1A1 P00352 2/20 0.52
HPGD P15428 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
NPC1 O15118 1/20 0.52
MAPT P10636 1/20 0.52
GFER P55789 1/20 0.52
KDM1A O60341 1/20 0.46
NFE2L2 Q16236 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
RELA Q04206 1/20 0.44
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31380868 1.00 CYP19A1 (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL5865516 1.00 CYP19A1 (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL29523090 0.79 KDM1A (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL2319434 0.79 KDM1A (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL7967117 0.79 KDM1A (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL29905760 0.79 KDM1A (0.53) CYP19A1MAOAMAOBGRM4HDAC6
SCHEMBL4540358 0.79 RAB9A (0.49) GRM4HDAC6KDM4EALDH1A1MEN1
SCHEMBL4540359 0.79 RAB9A (0.49) GRM4HDAC6KDM4EALDH1A1MEN1
SCHEMBL4537508 0.78 NOS3 (0.59) MAOBGRM4MEN1KMT2ANPC1
SCHEMBL4537505 0.78 NOS3 (0.59) MAOBGRM4MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034044-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2006-04-25 US disclosed
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER 2006-03-16 US disclosed
US-6951875-B2 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. (US) 2005-10-04 US disclosed
EP-1443926-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-11 EP disclosed
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent ALANINE ALEXANDER (FR) 2004-04-08 US disclosed
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent HOFFMANN-LA ROCHE INC. 2003-07-31 US disclosed
WO-2003037333-A1 PYRIDINE DERIVATIVES AS NMDA-RECEPTOR SUBTYPE BLOCKERS F. HOFFMANN-LA ROCHE AG (CH) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040068118-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP19A1 1693/4885MAOA 416/4885MAOB 249/4885
US-20030144525-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN1, GRIN2C CYP19A1 1693/4885MAOA 416/4885MAOB 249/4885
US-20060058354-A1 Conjugated aromatic compounds with a pyridine substituent GRIN2B, GRIN3A, GRIN2C CYP19A1 2025/4885MAOA 382/4885MAOB 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.